Overview

Safety Escalating Repeat IV, in Stroke Patients

Status:
Completed
Trial end date:
2011-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to is to test increasing repeat doses of GSK249320 compared to placebo in patients with stroke.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline